[
    [
        {
            "time": "",
            "original_text": "部分CRO&CDMO三季度业绩预告出炉，业绩分化明显 盈利能力下降",
            "features": {
                "keywords": [
                    "CRO",
                    "CDMO",
                    "三季度",
                    "业绩预告",
                    "业绩分化",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "部分CRO&CDMO三季度业绩预告出炉，业绩分化明显 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医疗板块异动多只个股涨停， 业绩支撑下四类标的股获机构青睐",
            "features": {
                "keywords": [
                    "医疗板块",
                    "异动",
                    "个股涨停",
                    "业绩支撑",
                    "机构青睐"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医疗板块异动多只个股涨停， 业绩支撑下四类标的股获机构青睐",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业:关注带量采购全国扩面,聚焦核心资产",
            "features": {
                "keywords": [
                    "医药生物",
                    "带量采购",
                    "全国扩面",
                    "核心资产"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药生物行业:关注带量采购全国扩面,聚焦核心资产",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]